Fig. 1From: Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysisMarkov model structure evaluating 2 treatment strategies (UAPR and CIUP) with 12 health statesBack to article page